Loading…

DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide. To identify biologically relevant genes with prognostic and therapeutic significance in PDAC, we first performed the microarray gene-expression profiling in 45 matching pairs of tumor and adjacent non-tumor tissues...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2012-02, Vol.7 (2), p.e31507
Main Authors: Zhang, Geng, Schetter, Aaron, He, Peijun, Funamizu, Naotake, Gaedcke, Jochen, Ghadimi, B Michael, Ried, Thomas, Hassan, Raffit, Yfantis, Harris G, Lee, Dong H, Lacy, Curtis, Maitra, Anirban, Hanna, Nader, Alexander, H Richard, Hussain, S Perwez
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide. To identify biologically relevant genes with prognostic and therapeutic significance in PDAC, we first performed the microarray gene-expression profiling in 45 matching pairs of tumor and adjacent non-tumor tissues from resected PDAC cases. We identified 36 genes that were associated with patient outcome and also differentially expressed in tumors as compared with adjacent non-tumor tissues in microarray analysis. Further evaluation in an independent validation cohort (N = 27) confirmed that DPEP1 (dipeptidase 1) expression was decreased (T:N ratio ∼0.1, P
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0031507